logo

For the Inventor, By the Inventor

Florence, KY, United States of America

Shire LLC


USPTO Granted Patents = 35

% Expired Patents = 22.9



Trademarks = 14

Forward Citations = 839

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Travis C Mickle (25 out of 95 patents)

silverMedal James Scott Moncrief (24 out of 30 patents)

bronzeMedal Suma Krishnan (23 out of 44 patents)

4.  Christopher Lauderback (23 out of 27 patents)

5.  Thomas Piccariello (22 out of 41 patents)

6.  Barney Bishop (18 out of 32 patents)

7.  Christopher Verbicky (16 out of 19 patents)

8.  Bernhard J Paul (16 out of 21 patents)

9.  Robert A Oberlender (15 out of 20 patents)

10.  Bernard Thomas Golding (3 out of 30 patents)

11.  David Pierce (3 out of 3 patents)

12.  Christal Mickle (2 out of 20 patents)

13.  Amir Shojaei (2 out of 7 patents)

14.  Stephanie Read (2 out of 2 patents)

15.  Paul Hodgkins (2 out of 2 patents)


Core Competencies:
Controlled Dose
Drug Delivery
Pharmaceutical Compositions
Abuse-Resistant
Anagrelide
Lanthanum Compounds
Sustained Release
Dendritic Encapsulation
Quinazolines
Active Agents
Oxycodone

35 patents:

1. 9173857 - Controlled dose drug delivery system (2015-11-03),
2. 9067944 - Process for the preparation of anagrelide and analogues thereof (2015-06-30),
3. 9023397 - Capsule and powder formulations containing lanthanum compounds (2015-05-05),
4. 8980327 - Capsule and powder formulations containing lanthanum compounds (2015-03-17),
5. 8846100 - Controlled dose drug delivery system (2014-09-30),
6. 8697132 - Capsule and powder formulations containing lanthanum compounds (2014-04-15),
7. 8530651 - Process for the preparation of anagrelide and analogues (2013-09-10),
8. 8394813 - Active agent delivery systems and methods for protecting and administering active agents (2013-03-12),
9. 8343927 - Pharmaceutical compositions for prevention of overdose or abuse (2013-01-01),
10. 8304420 - Substituted quinazolines for reducing platelet count (2012-11-06),
11. 8263119 - Capsule formulations containing lanthanum compounds (2012-09-11),
12. 8133881 - Carbohydrate conjugates to prevent abuse of controlled substances (2012-03-13),
13. 8106016 - Compounds and compositions for prevention of overdose of oxycodone (2012-01-31),
14. 7910597 - Substituted quinazolines (2011-03-22),
15. 7723305 - Abuse-resistant amphetamine prodrugs (2010-05-25),
Company Overview
Shire LLC, based in Florence, KY, specializes in the development and manufacturing of innovative therapies for rare diseases and complex conditions. The company focuses on advancing treatments in areas such as hematology, immunology, and neuroscience, leveraging cutting-edge research and technology to address unmet medical needs. With a commitment to improving patient outcomes, Shire collaborates with healthcare professionals and stakeholders to deliver effective solutions that enhance the quality of life for individuals facing challenging health issues.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Shire LLC USPTO Patent Assignee Logo
35 Patents

#3 in Florence, KY

#35 in Kentucky

#9,756 in US

#19,181 in the World

Florence, KY (US)
Florence, KY, United States of America

Shire LLC

Forward Citations = 839

28 inventors:

goldMedal Travis C Mickle (25 out of 95 patents)

silverMedal James Scott Moncrief (24 out of 30 patents)

bronzeMedal Suma Krishnan (23 out of 44 patents)

4.  Christopher Lauderback (23 out of 27 patents)

5.  Thomas Piccariello (22 out of 41 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shire LLC. Retrieved from https://idiyas.com/company/shire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…